Skip to main content
WST
NYSE Life Sciences

West Pharma Lifts FY EPS Outlook to $9.38-$9.48 After Q3 Beat

Tom Rudovsky · Reported by dpa-AFX
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$410.95
Mkt Cap
$28.406B
52W Low
$223.83
52W High
$404.985
52W Position info
84% above low
Off High info
at 52W high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

WST sits 84% above its 52-week low of $223.83.

Summary

West Pharmaceutical raised full-year adjusted EPS guidance to $9.38-$9.48 from $8.85-$9.05 and revenue to $3.41-$3.42 billion from $3.345-$3.380 billion. The raise follows a strong third quarter: net income jumped to $214.0 million, or $3.02 per share, from $140.0 million, or $1.92 per share, a year earlier, on revenue of $874.5 million, up 8.7%. Adjusted EPS came in at $2.66. Shares rose nearly 2% in premarket trading after closing at $403.64 Wednesday, and the stock is already trading near its 52-week high. The guidance raise follows the 8-K filed this morning confirming the Q3 beat and the new $950 million credit agreement signed October 26th.

At the time of this announcement, WST was trading at $410.95 on NYSE in the Life Sciences sector, with a market capitalization of approximately $28.4B. The 52-week trading range was $223.83 to $404.99. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: dpa-AFX.


Price Chart

Share this article

Copied!

WST - Latest Insights

WST
Oct 29, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $416.67
Real-time Price: $416.42 info
Change: -$0.250 (-0.06%) info
Market Cap: $29.008B info
WST
Oct 29, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $410.95
Real-time Price: $416.42 info
Change: +$5.47 (+1%) info
Market Cap: $29.008B info
WST
Oct 29, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $398.00
Real-time Price: $416.42 info
Change: +$18.42 (+5%) info
Market Cap: $29.008B info
WST
Jul 23, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $354.08
Real-time Price: $416.42 info
Change: +$62.34 (+18%) info
Market Cap: $29.008B info
WST
Jul 23, 2026, 7:14 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $380.00
Real-time Price: $416.42 info
Change: +$36.42 (+10%) info
Market Cap: $29.008B info